Terms: = Lung cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716
119 results:
1. [High LINC00626 expression promotes esophagogastric junction adenocarcinoma metastasis: the mediating role of the jak1/STAT3/KHSRP axis].
Zhang F; Fan L; Kang X; Wei H; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):541-552. PubMed ID: 38597446
[TBL] [Abstract] [Full Text] [Related]
2. EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation.
Qin Z; Yue M; Tang S; Wu F; Sun H; Li Y; Zhang Y; Izumi H; Huang H; Wang W; Xue Y; Tong X; Mori S; Taki T; Goto K; Jin Y; Li F; Li FM; Gao Y; Fang Z; Fang Y; Hu L; Yan X; Xu G; Chen H; Kobayashi SS; Ventura A; Wong KK; Zhu X; Chen L; Ren S; Chen LN; Ji H
J Exp Med; 2024 Mar; 221(3):. PubMed ID: 38284990
[TBL] [Abstract] [Full Text] [Related]
3. Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell lung cancer.
Ricciuti B; Lamberti G; Puchala SR; Mahadevan NR; Lin JR; Alessi JV; Chowdhury A; Li YY; Wang X; Spurr L; Pecci F; Di Federico A; Venkatraman D; Barrichello AP; Gandhi M; Vaz VR; Pangilinan AJ; Haradon D; Lee E; Gupta H; Pfaff KL; Welsh EL; Nishino M; Cherniack AD; Johnson BE; Weirather JL; Dryg ID; Rodig SJ; Sholl LM; Sorger P; Santagata S; Umeton R; Awad MM
J Clin Oncol; 2024 Apr; 42(11):1311-1321. PubMed ID: 38207230
[TBL] [Abstract] [Full Text] [Related]
4. Sensory neurons promote immune homeostasis in the lung.
Tamari M; Del Bel KL; Ver Heul AM; Zamidar L; Orimo K; Hoshi M; Trier AM; Yano H; Yang TL; Biggs CM; Motomura K; Shibuya R; Yu CD; Xie Z; Iriki H; Wang Z; Auyeung K; Damle G; Demircioglu D; Gregory JK; Hasson D; Dai J; Chang RB; Morita H; Matsumoto K; Jain S; Van Dyken S; Milner JD; Bogunovic D; Hu H; Artis D; Turvey SE; Kim BS
Cell; 2024 Jan; 187(1):44-61.e17. PubMed ID: 38134932
[TBL] [Abstract] [Full Text] [Related]
5. The necroptosis signature and molecular mechanism of lung squamous cell carcinoma.
Song GQ; Wu HM; Ji KJ; He TL; Duan YM; Zhang JW; Hu GQ
Aging (Albany NY); 2023 Nov; 15(22):12907-12926. PubMed ID: 37976123
[TBL] [Abstract] [Full Text] [Related]
6. Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of lung cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation.
Yang SR; Gedvilaite E; Ptashkin R; Chang J; Ziegler J; Mata DA; Villafania LB; Nafa K; Hechtman JF; Benayed R; Zehir A; Benhamida J; Arcila ME; Mandelker D; Rudin CM; Paik PK; Drilon A; Schoenfeld AJ; Ladanyi M
J Thorac Oncol; 2024 Mar; 19(3):409-424. PubMed ID: 37838086
[TBL] [Abstract] [Full Text] [Related]
7. RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast cancer and Beyond.
Wu J; Subbiah V
Cancer Res; 2023 Oct; 83(19):3159-3161. PubMed ID: 37779428
[TBL] [Abstract] [Full Text] [Related]
8. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/jak1/STAT3 signaling by sponging miR-647.
Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M
Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785
[TBL] [Abstract] [Full Text] [Related]
9. Integration analysis using bioinformatics and experimental validation on the clinical and biological significance of TSLP in cancers.
Qu H; Liu X; Jiang T; Huang G; Cai H; Xing D; Mao Y; Zheng X
Cell Signal; 2023 Nov; 111():110874. PubMed ID: 37640192
[TBL] [Abstract] [Full Text] [Related]
10. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E; Rawlik K; Bretherick AD; Qi T; Wu Y; Nassiri I; McConkey GA; Zechner M; Klaric L; Griffiths F; Oosthuyzen W; Kousathanas A; Richmond A; Millar J; Russell CD; Malinauskas T; Thwaites R; Morrice K; Keating S; Maslove D; Nichol A; Semple MG; Knight J; Shankar-Hari M; Summers C; Hinds C; Horby P; Ling L; McAuley D; Montgomery H; Openshaw PJM; Begg C; Walsh T; Tenesa A; Flores C; Riancho JA; Rojas-Martinez A; Lapunzina P; ; ; ; ; Yang J; Ponting CP; Wilson JF; Vitart V; Abedalthagafi M; Luchessi AD; Parra EJ; Cruz R; Carracedo A; Fawkes A; Murphy L; Rowan K; Pereira AC; Law A; Fairfax B; Hendry SC; Baillie JK
Nature; 2023 May; 617(7962):764-768. PubMed ID: 37198478
[TBL] [Abstract] [Full Text] [Related]
11. EPN3 plays oncogenic role in non-small cell lung cancer by activating the jak1/2-STAT3 pathway.
Meng J; Zhang C; Zhu N; Zhang C; Liu M; Han Z; Li Y
Environ Toxicol; 2023 Aug; 38(8):1968-1979. PubMed ID: 37186036
[TBL] [Abstract] [Full Text] [Related]
12. Triptolide reduces PD-L1 through the EGFR and IFN-γ/IRF1 dual signaling pathways.
Xie Y; Ding J; Gao J; Zhang J; Cen S; Zhou J
Int Immunopharmacol; 2023 May; 118():109993. PubMed ID: 36931170
[TBL] [Abstract] [Full Text] [Related]
13. Novel lignans from Zanthoxylum nitidum and antiproliferation activity of sesaminone in osimertinib-resistant non-small cell lung cancer cells.
Wang CY; Qin F; Wang CG; Kim D; Li JJ; Chen XL; Wang HS; Lee SK
Bioorg Chem; 2023 May; 134():106445. PubMed ID: 36893545
[TBL] [Abstract] [Full Text] [Related]
14. Effective personalized neoantigen vaccine plus anti-PD-1 in a PD-1 blockade-resistant lung cancer patient.
Gao S; Wang J; Zhu Z; Fang J; Zhao Y; Liu Z; Qin H; Wei Y; Xu H; Dan X; Yang L; Xu Q
Immunotherapy; 2023 Feb; 15(2):57-69. PubMed ID: 36651232
[TBL] [Abstract] [Full Text] [Related]
15. IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer.
He Y; Luo W; Liu Y; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Ma YS; Yang H; Xu K; Zhang X; Xiao Y; Zhang P; Liang Y; Fu D; Yao F; Hu G
J Clin Invest; 2022 Oct; 132(20):. PubMed ID: 36006737
[TBL] [Abstract] [Full Text] [Related]
16. circFCHO2 promotes gastric cancer progression by activating the jak1/STAT3 pathway via sponging miR-194-5p.
Zhang Z; Sun C; Zheng Y; Gong Y
Cell Cycle; 2022 Oct; 21(20):2145-2164. PubMed ID: 35708677
[TBL] [Abstract] [Full Text] [Related]
17. Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.
Liu C; Yang L; Xu H; Zheng S; Wang Z; Wang S; Yang Y; Zhang S; Feng X; Sun N; Wang Y; He J
BMC Med; 2022 May; 20(1):187. PubMed ID: 35550592
[TBL] [Abstract] [Full Text] [Related]
18. Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK-STAT signaling in macrophages by perturbing lipid raft structures.
Hammoud MK; Dietze R; Pesek J; Finkernagel F; Unger A; Bieringer T; Nist A; Stiewe T; Bhagwat AM; Nockher WA; Reinartz S; Müller-Brüsselbach S; Graumann J; Müller R
Mol Oncol; 2022 Sep; 16(17):3146-3166. PubMed ID: 35451191
[TBL] [Abstract] [Full Text] [Related]
19. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma Cells.
Huang J; Zhou Y; Zhong X; Su F; Xu L
Oxid Med Cell Longev; 2022; 2022():3129155. PubMed ID: 35281458
[TBL] [Abstract] [Full Text] [Related]
20. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3.
Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530
[TBL] [Abstract] [Full Text] [Related]
[Next]
